Qualitative analysis of Adenomatous Polyposis Coli promoter: Hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker

[1]  K. Roux,et al.  Optimization and troubleshooting in PCR. , 2009, Cold Spring Harbor protocols.

[2]  E. Cho,et al.  CpG island hypermethylation of E‐cadherin (CDH1) and integrin α4 is associated with recurrence of early stage esophageal squamous cell carcinoma , 2008, International journal of cancer.

[3]  Steven Piantadosi,et al.  DNA methylation markers and early recurrence in stage I lung cancer. , 2008, The New England journal of medicine.

[4]  J. Ellinger,et al.  Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer. , 2008, The Journal of urology.

[5]  M. Caruso,et al.  Methylation of TIMP3 in esophageal squamous cell carcinoma. , 2008, World journal of gastroenterology.

[6]  Tetsuo Ito,et al.  Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma , 2007, Oncogene.

[7]  M. Esteller.  Epigenetic gene silencing in cancer: the DNA hypermethylome. , 2007, Human molecular genetics.

[8]  J. Herman,et al.  Accumulation of Promoter Methylation Suggests Epigenetic Progression in Squamous Cell Carcinoma of the Esophagus , 2006, Clinical Cancer Research.

[9]  M. Mohagheghi,et al.  Epidemiology of esophageal cancer in the high-risk population of iran. , 2006, Asian Pacific journal of cancer prevention : APJCP.

[10]  N. Matsubara,et al.  Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa , 2006, Gut.

[11]  F. Bosman,et al.  Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus , 2006, Oncogene.

[12]  J. Califano,et al.  DCC promoter hypermethylation in esophageal squamous cell carcinoma , 2006, International journal of cancer.

[13]  M. Augustus,et al.  Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers , 2006, International journal of cancer.

[14]  M. Nowak,et al.  Dynamics of colorectal cancer. , 2005, Seminars in cancer biology.

[15]  F. J. Ramos,et al.  Novel targeted therapies in the treatment of gastric and esophageal cancer. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  Y. Gruel,et al.  Improved PCR method for amplification of GC-rich DNA sequences , 2005, Molecular biotechnology.

[17]  C. Sherr,et al.  Principles of Tumor Suppression , 2004, Cell.

[18]  Tsung-Teh Wu,et al.  Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  Hwoong-Yong Jung,et al.  Profile of Aberrant CpG Island Methylation along Multistep Gastric Carcinogenesis , 2003, Laboratory Investigation.

[20]  T. Godfrey,et al.  The role of tumor suppressor genes in esophageal cancer. , 2002, Minerva Chirurgica.

[21]  R. Malekzadeh,et al.  Endoscopic esophageal cancer survey in the western part of the Caspian Littoral. , 2002, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[22]  Xin Zhao,et al.  Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. , 2002, Carcinogenesis.

[23]  A. Millar,et al.  Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype. , 2002, Cancer research.

[24]  K. Hemminki,et al.  Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation. , 2002, Carcinogenesis.

[25]  Christoph Grunau,et al.  Bisulfite genomic sequencing: systematic investigation of critical experimental parameters , 2001, Nucleic Acids Res..

[26]  David Sidransky,et al.  Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival , 2001, Oncogene.

[27]  P. Laird,et al.  Adenocarcinoma Epigenetic Patterns in the Progression of Esophageal Updated Version , 2001 .

[28]  M. Hollstein,et al.  Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. , 2001, Cancer research.

[29]  N. Hu,et al.  Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  H. Gabbert,et al.  Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus. , 2000, American journal of clinical pathology.

[31]  S. Groshen,et al.  Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. , 2000, Journal of the National Cancer Institute.

[32]  A. Sepehr,et al.  Oesophageal cancer among the Turkomans of northeast Iran , 2000, British Journal of Cancer.

[33]  Tsung-Teh Wu,et al.  Mutations in β-Catenin and APC Genes are Uncommon in Esophageal and Esophagogastric Junction Adenocarcinomas , 2000, Modern Pathology.

[34]  P. Laird,et al.  Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. , 2000, Cancer research.

[35]  J. Herman,et al.  Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. , 2000, Cancer research.

[36]  D. Harpole,et al.  Molecular biology of esophageal cancer. , 2000, Chest surgery clinics of North America.

[37]  S. Nishizuka,et al.  Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia , 2000, Oncogene.

[38]  B. Tycko,et al.  Epigenetic gene silencing in cancer. , 2000, The Journal of clinical investigation.

[39]  S. Shi,et al.  Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[41]  N. Sato,et al.  Additive effects of bovine serum albumin, dithiothreitol and glycerolon PCR , 1998, Biochemistry and molecular biology international.

[42]  C. Mello,et al.  Wnt Signaling and an APC-Related Gene Specify Endoderm in Early C. elegans Embryos , 1997, Cell.

[43]  G. Thomas,et al.  Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers , 1997, International journal of cancer.

[44]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[45]  A. Olek,et al.  A modified and improved method for bisulphite based cytosine methylation analysis. , 1996, Nucleic acids research.

[46]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. Liotta,et al.  Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. , 1996, Cancer research.

[48]  J. Herman,et al.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.

[49]  R. Weinberg,et al.  Suppression of intestinal neoplasia by DNA hypomethylation , 1995, Cell.

[50]  Jing Yin,et al.  Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus. , 1994, Cancer research.

[51]  K. Kinzler,et al.  APC gene mutations in the mutation cluster region are rare in esophageal cancers. , 1994, Gastroenterology.

[52]  G. Tamura,et al.  Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas , 1994, Virchows Archiv.

[53]  S. Mori,et al.  Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. , 1994, Cancer research.

[54]  Y. Yuasa,et al.  Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. , 1994, Cancer research.

[55]  S. Mori,et al.  Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. , 1994, Cancer research.

[56]  N. Muñoz.  Epidemiological Aspects of Oesophageal Cancer , 1993, Endoscopy.

[57]  W. Ballhausen,et al.  Identification of an alternative 5′ untranslated region of the adenomatous polyposis coli gene , 1993, Human Genetics.

[58]  Patricia L. Blount,et al.  Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. , 1992, Cancer research.

[59]  D. Cox,et al.  Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. , 1992, American journal of human genetics.

[60]  Patricia L. Blount,et al.  Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[61]  J. Roth,et al.  p53 gene mutations in Barrett's epithelium and esophageal cancer. , 1991, Cancer research.

[62]  R. Rozen,et al.  A rapid procedure for extracting genomic DNA from leukocytes. , 1991, Nucleic acids research.

[63]  N. Day,et al.  Dietary factors and esophageal cancer in the Caspian Littoral of Iran. , 1975, Cancer research.

[64]  J. Kmet,et al.  Esophageal Cancer in the Caspian Littoral of Iran: Initial Studies , 1972, Science.

[65]  M. Sasiadek,et al.  Aberrant epigenetic patterns in the etiology of gastrointestinal cancers , 2010, Journal of Applied Genetics.

[66]  L. Tanoue.  DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer , 2009 .

[67]  P. Hainaut,et al.  Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran , 2002, Oncogene.

[68]  J. Walter,et al.  Bisulfite-based methylation analysis of imprinted genes. , 2001, Methods in molecular biology.

[69]  D. Fang,et al.  [The possible role of loss of heterozygosity at APC, MCC and DCC genetic loci in esophageal carcinoma]. , 1999, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[70]  G. Yang,et al.  Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. , 1999, Carcinogenesis.

[71]  W. Blot,et al.  The changing epidemiology of esophageal cancer. , 1999, Seminars in oncology.

[72]  K. Becker,et al.  [Frequency and significance of APC gene mutations in malignant degeneration of Barrett esophagus]. , 1998, Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress.

[73]  H. Li,et al.  [Mutation of tumor suppressor genes APC and MCC in human esophageal cancer]. , 1995, Zhonghua zhong liu za zhi [Chinese journal of oncology].